Hanmi Science Q3 operating profit ₩19.2B; annual revenue to top ₩1T (roundup)
Predicted impact: Low
Roundup of Q3 operating profit of about 19.2 billion won; already covered by preliminary earnings.
Hanmi Science한미사이언스
008930 · KOSPI · ₩008930 · 한미사이언스
₩42,200▲ ₩750 (1.81%)End-of-day · Oct 29, 2026 · End-of-day prices.
Hanmi Science cumulative sales top ₩1T; business-type holding company on track
Predicted impact: Low
Q3 operating profit of about 19.2 billion won is small; preliminary earnings were already disclosed.
Hanmi Science cumulative sales surpass ₩1T; operating profit falls in third quarter
Predicted impact: Low
Q3 operating profit decline is small against revenue; preliminary earnings already reported in last 14 days.
Hanmi Science Q3 cumulative revenue tops ₩1T; growth in distribution and healthcare
Predicted impact: Low
Q3 cumulative revenue above ₩1T was already covered by preliminary earnings disclosure.
Hanmi Science Q3 operating profit ₩19.2B, down 51.3% year on year
Predicted impact: Low
Q3 profit down 51.3% was previewed in preliminary earnings filing; small versus market value.
Complaint Filed Against Shin Dong-kook and Son, Largest Shareholders of Hanmi Science, Referred to Seoul Metropolitan Police Agency's Financial Investigation Unit
Predicted impact: Medium
Criminal complaint against largest shareholders; ongoing control dispute with financial probe.
Shin Dong-kook faces controversy over seizure of Hanmi Science shares and capital markets law violation; lending syndicate also watching closely
High impactPredicted impact: High· Actual: −4.3% vs sector, volume 0.9× normal (5 trading days)
Share seizure and suspected capital markets law violation affecting voting rights at a holding company.
Hanmi Science Shin Dong-kook 'Public Tender Offer Rule' Controversy
Predicted impact: Medium· Actual: −4.3% vs sector, volume 0.9× normal (5 trading days)
Shin Dong-kook tender offer and voting rights dispute already reported; ongoing governance controversy.
Shin Dong-kook Suspected of Violating Tender Offer Obligations in Hankook Science Stake Purchase, Raising Concerns Over Voting Rights Restrictions
Predicted impact: Medium· Actual: −4.3% vs sector, volume 0.9× normal (5 trading days)
Tender offer violation and voting rights concerns; related shareholder dispute already reported in last 14 days.
Hankook Science Management Dispute: Will Shin Dong-guk's Voting Rights Be Restricted?
Predicted impact: Medium· Actual: −4.3% vs sector, volume 0.9× normal (5 trading days)
Ongoing control dispute and possible voting-rights restriction; a dispute already flagged in recent items, impact potentially large.
[BioSnap] Hanmi Science Promotes Healthy Blood Donation Culture
Predicted impact: Low· Actual: −4.3% vs sector, volume 0.9× normal (5 trading days)
Blood donation promotion campaign; routine corporate social activity with no financial impact.
Hanmi Science supports Seoul Blood Donation Houses with 42 health drinks in partnership with Korean Red Cross
Predicted impact: Low· Actual: +2.5% vs sector, volume 1.0× normal (5 trading days)
Small health drink donation to blood donation houses; immaterial to valuation.
Shin Dong-kook's Hanmi Science Shares Provisionally Seized Again; Warning Signs Over ₩500B Mortgage Loan
Predicted impact: Medium· Actual: −3.7% vs sector, volume 1.1× normal (5 trading days)
Repeated share seizure tied to ₩500B mortgage loan; signals major shareholder financial stress.
Also known as: Hanmi Science / 한미사이언스 / 008930 / KRX:008930
Source: KRX statistical information